Page 12 - Research In Multiple Sclerosis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AI Tool Reveals MS Drug Interactions, Offers Safer Options

Clinicians prescribing a drug for patients with multiple sclerosis who are on multiple treatments may in future use AI to identify potential interactions and suggest safer options, new data suggest.

Pavan bhargavaMichael heckerEuropean committee for treatmentRostock university medical centerResearch in multiple sclerosisJohns hopkins precision medicine centerDepartment of neurologyAmericas committee for treatmentJoint european committeeMultiple sclerosis americas committeeMultiple sclerosisMedscape medical newsMultiple sclerosis msMultiple sclerosisDrug interactionsRelapsing remitting multiple sclerosis

Ocrelizumab Benefit Confirmed in Older Patients With MS

The relapse benefit of ocrelizumab in multiple sclerosis is confirmed for the first time in patients 60 and older starting therapy, say researchers in findings they hope will inform choices.

South australiaYi chao foongOcrelizumab ocrevusPavan bhargavaAmericas committee for treatmentJohns hopkins precision medicine centerResearch in multiple sclerosisCentral clinical schoolEuropean committee for treatmentMonash universityDepartment of neuroscienceJoint european committeeMultiple sclerosis americas committeeMultiple sclerosisExpanded disability status scaleMedscape medical

Late-breaking data for Roche s BTK inhibitor fenebrutinib show brain penetration and significant reduction in lesions in patients with relapsing multiple sclerosis

Late-breaking data for Roche s BTK inhibitor fenebrutinib show brain penetration and significant reduction in lesions in patients with relapsing multiple sclerosis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesBirgit masjostKarsten kleineBruno eschliLevi garrawayNathalie altermattSileia urechSimon goldsboroughKirti pandeySabine borngrLoren kalmRebekka schnellGerard tobinResearch in multiple sclerosisHead of global product developmentRoche group

Late-Breaking Data for Genentech s BTK Inhibitor Fenebrutinib Show Brain Penetration and Significant Reduction in Lesions in Patients With Relapsing Multiple Sclerosis

Late-Breaking Data for Genentech s BTK Inhibitor Fenebrutinib Show Brain Penetration and Significant Reduction in Lesions in Patients With Relapsing Multiple Sclerosis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSouth san franciscoLoren kalmMichelle mccourtLevi garrawayBruno eschliJo dulayResearch in multiple sclerosisGlobal product developmentRoche groupAmericas committeesMultiple sclerosisGlobal productImportant safetyMultifocal leukoencephalopathyOcrevus pregnancy

ECTRIMS 2023: Personalized Tysabri dosing shows good efficacy | Multiple Sclerosis News Today

ECTRIMS 2023: Personalized Tysabri dosing shows good efficacy | Multiple Sclerosis News Today
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

Noord hollandAlyssa tooropMs center amsterdamEuropean committee for treatmentResearch in multiple sclerosisAmericas committee for treatmentEuropean committeeMultiple sclerosisAmericas committee